LTR Pharma drug ROXUS begins US prescription fulfillment
Shares of LTR Pharma (LTP.AX) rose as much as 13.3% to A$0.560 after the company said its erectile dysfunction treatment ROXUS began prescription fulfillment in the US via online platform Mavrox. The stock is down 28.3% year-to-date.